Table 2

Adverse events and reactions to antimalarials in patients with rheumatoid arthritis during observation period

AE/ARPatients without CVD/PH
(n=249)
Patients with previous CVD/PH (n=95)Total n=344 (%)
Retinal toxicity10030130 (37.9)
Gastrointestinal AEs8320103 (30.0)
Dermatological ARs6545110 (31.8)
Severe dizziness101 (0.3)
CVD AEs/ARs000 (0.0)
  • AE, adverse event; AR, adverse reaction; CVD, cardiovascular disease; PH, primary hypertension.